hb-as02v
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Mar 1, 2006 (NCT00291954)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Hepatitis B virusImmunity, active
Hepatitis B virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hb-as02v
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00291954 | Phase 3 | Mar 1, 2006 | GlaxoSmithKline, Henogen |
| NCT00291980 | Phase 3 | Mar 1, 2006 | GlaxoSmithKline, Henogen |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 2 | 0 | 1 | 2006 |
| Henogen | For profit | 2 | 2 | 1 | 2006 |
2 organizations
Page 1 / 1